Preexposure to live Brugia malayi microfilariae alters the innate response of human dendritic cells to Mycobacterium tuberculosis

Journal of Infectious Diseases

Volumn 193, Issue 2, 2006, Pages 196-204

  Talaat, Kawsar R ^a   Bonawitz, Rachael E ^a,b   Domenech, Pilar ^a   Nutman, Thomas B ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CD4 ANTIGEN; CHEMOKINE; CYTOKINE; GAMMA INTERFERON; HLA DR3 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 3; INTERLEUKIN 1BETA;

ANTIGEN EXPRESSION; ARTICLE; BRUGIA MALAYI; CELL DIFFERENTIATION; CELLULAR IMMUNITY; COMORBIDITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HOST PARASITE INTERACTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFECTION SENSITIVITY; MACROPHAGE; MICROFILARIA; MONOCYTE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; TH1 CELL;

ANIMALS; ANTIGENS, CD14; ANTIGENS, CD40; BRUGIA MALAYI; CD4-POSITIVE T-LYMPHOCYTES; CELL ADHESION MOLECULES; CELLS, CULTURED; COCULTURE TECHNIQUES; DENDRITIC CELLS; HLA-DR ANTIGENS; HUMANS; IMMUNITY, NATURAL; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON-ALPHA; INTERLEUKIN-1; LECTINS, C-TYPE; MYCOBACTERIUM TUBERCULOSIS; RECEPTORS, CELL SURFACE;

EID: 30944436664     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/498912     Document Type: Article

References (48)

1. Frieden TR, Sterling TR, Munsiff SS, Watt CJ, Dye C. Tuberculosis. Lancet 2003; 362:887-99.
2. Molyneux DH, Bradley M, Hoerauf A, Kyelem D, Taylor MJ. Mass drug treatment for lymphatic filariasis and onchocerciasis. Trends Parasitol 2003; 19:516-22.
3. Lipner E, Kolipan C, Gopi P, et al. An epidemiologic assessment of filarial, interstinal helminth and mycobacterial coinfection in south India: BCG vaccination protects from hookworm infection but helminths fail to influence subsequent responses to M. tuberculosis. Am J Trop Med Hyg (in press).
4. Borkow G, Weisman Z, Leng Q, et al. Helminths, human immunodeficiency virus and tuberculosis. Scand J Infect Dis 2001; 33:568-71.
5. Tawill SA, Gallin M, Erttmann KD, Kipp W, Bamuhiiga J, Buttner DW. Impaired antibody responses and loss of reactivity to Onchocerca volvulus antigens by HIV-seropositive onchocerciasis patients. Trans R Soc Trop Med Hyg 1996; 90:85-9.
6. Doffinger R, Jouanguy E, Altare F, et al. Inheritable defects in interleukin-12- and interferon-γ-mediated immunity and the Th1/Th2 paradigm in man. Allergy 1999; 54:409-12.
7. Keane J, Gershon S, Wise RP, et al. Tuberculosis associated with infliximab, a tumor necrosis factor α-neutralizing agent. N Engl J Med 2001; 345:1098-104.
8. Al-Attiyah R, Mustafa AS, Abal AT, Madi NM, Andersen P. Restoration of mycobacterial antigen-induced proliferation and interferon-γ responses in peripheral blood mononuclear cells of tuberculosis patients upon effective chemotherapy. FEMS Immunol Med Microbiol 2003; 38:249-56.
9. Flynn JL, Chan J. Immunology of tuberculosis. Annu Rev Immunol 2001; 19:93-129.
10. Elias D, Wolday D, Akuffo H, Petros B, Bronner U, Britton S. Effect of deworming on human T cell responses to mycobacterial antigens in helminth-exposed individuals before and after bacille Calmette-Guérin (BCG) vaccination. Clin Exp Immunol 2001; 123:219-25.
11. Stewart GR, Boussinesq M, Coulson T, Elson L, Nutman T, Bradley JE. Onchocerciasis modulates the immune response to mycobacterial antigens. Clin Exp Immunol 1999; 117:517-23.
12. Cervi L, MacDonald AS, Kane C, Dzierszinski F, Pearce EJ. Dendritic cells copulsed with microbial and helminth antigens undergo modified maturation, segregate the antigens to distinct intracellular compartments, and concurrently induce microbe-specific Th1 and helminth-specific Th2 responses. J Immunol 2004; 172:2016-20.
13. Tristao-Sa R, Ribeiro-Rodrigues R, Johnson LT, Pereira FE, Dietze R. Intestinal nematodes and pulmonary tuberculosis. Rev Soc Bras Med Trop 2002; 35:533-5.
14. Steel C, Ottesen EA, Weller PF, Nutman TB. Worm burden and host responsiveness in Wuchereria bancrofti infection: use of antigen detection to refine earlier assessments from the South Pacific. Am J Trop Med Hyg 2001; 65:498-503.
15. Balasubramanian R, Garg R, Santha T, et al. Gender disparities in tuberculosis: report from a rural DOTS programme in south India. Int J Tuberc Lung Dis 2004; 8:323-32.
16. Chadha VK, Vaidyanathan PS, Jagannatha PS, Unnikrishnan KP, Savanur SJ, Mini PA. Annual risk of tuberculous infection in the western zone of India. Int J Tuberc Lung Dis 2003; 7:536-42.
17. Kolappan C, Gopi PG, Subramani R, et al. Estimation of annual risk of tuberculosis infection (ARTI) among children aged 1-9 years in the south zone of India. Int J Tuberc Lung Dis 2004; 8:418-23.
18. Semnani RT, Sabzevari H, Iyer R, Nutman TB. Filarial antigens impair the function of human dendritic cells during differentiation. Infect Immun 2001; 69:5813-22.
19. Aoki K, Matsumoto S, Hirayama Y, et al. Extracellular mycobacterial DNA-binding protein 1 participates in mycobacterium-lung epithelial cell interaction through hyaluronic acid. J Biol Chem 2004; 279: 39798-806.
20. Giacomini E, Iona E, Ferroni L, et al. Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response. J Immunol 2001; 166:7033-41.
21. Hogan KJ, Shaw S. Immunomagnetic purification of T cell populations. In: Coligan JE, Bierer BE, Marguilies DH, et al., eds. Current protocols in immunology. Vol 2. New York: Wiley Interscience, 1994:7.4.1-3.
22. Henderson RA, Watkins SC, Flynn IL. Activation of human dendritic cells following infection with Mycobacterium tuberculosis. J Immunol 1997; 159:635-43.
23. Stenger S, Niazi KR, Modlin RL. Downregulation of CD1 on antigen-presenting cells by infection with Mycobacterium tuberculosis. J Immunol 1998; 161:3582-8.
24. + T cells. J Immunol 2003; 171:1950-60.
25. Semnani RT, Nutman TB. Toward an understanding of the interaction between filarial parasites and host antigen-presenting cells. Immunol Rev 2004; 201:127-38.
26. Ottesen EA, Weller PF, Heck L. Specific cellular immune unresponsiveness in human filariasis. Immunology 1977; 33:413-21.
27. Fortsch D, Rollinghoff M, Stenger S. IL-10 converts human dendritic cells into macrophage-like cells with increased antibacterial activity against virulent Mycobacterium tuberculosis. J Immunol 2000; 165:978-87.
28. Tailleux L, Neyrolles O, Honore-Bouakline S, et al. Constrained intracellular survival of Mycobacterium tuberculosis in human dendritic cells. J Immunol 2003; 170:1939-48.
29. Geijtenbeek TB, Kwon DS, Torensma R, et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000; 100:587-97.
30. Kaufmann SH, Schaible UE. A dangerous liaison between two major killers: Mycobacterium tuberculosis and HIV target dendritic cells through DC-SIGN. J Exp Med 2003; 197:1-5.
31. Su SV, Hong P, Baik S, Negrete OA, Gurney KB, Lee B. DC-SIGN binds to HIV-1 glycoprotein 120 in a distinct but overlapping fashion compared with ICAM-2 and ICAM-3. J Biol Chem 2004; 279:19122-32.
32. Feng ZH, Wang QC, Nie QH, Jia ZS, Zhou YX. DC-SIGN: binding receptor for HCV? World J Gastroenterol 2004; 10:925-9.
33. Alvarez CP, Lasala F, Carrillo J, Muniz O, Corbi AL, Delgado R. C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans. J Virol 2002; 76:6841-4.
34. Simmons G, Reeves JD, Grogan CC, et al. DC-SIGN and DC-SIGNR bind Ebola glycoproteins and enhance infection of macrophages and endothelial cells. Virology 2003; 305:115-23.
35. Colmenares M, Puig-Kroger A, Pello OM, Corbi AL, Rivas L. Dendritic cell (DC)-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin (DC-SIGN, CD209), a C-type surface lectin in human DCs, is a receptor for Leishmania amastigotes. J Biol Chem 2002; 277:36766-9.
36. van Die I, van Vliet SJ, Nyame AK, et al. The dendritic cell-specific C-type lectin DC-SIGN is a receptor for Schistosoma mansoni egg antigens and recognizes the glycan antigen Lewis x. Glycobiology 2003; 13:471-8.
37. Tailleux L, Schwartz O, Herrmann JL, et al. DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. J Exp Med 2003; 197:121-7.
38. Geijtenbeek TB, van Vliet SJ, Koppel EA, et al. Mycobacteria target DC-SIGN to suppress dendritic cell function. J Exp Med 2003; 197:7-17.
39. Mwandumba HC, Russell DG, Nyirenda MH, et al. Mycobacterium tuberculosis resides in nonacidified vacuoles in endocytically competent alveolar macrophages from patients with tuberculosis and HIV infection. J Immunol 2004; 172:4592-8.
40. Giosue S, Casaini M, Alemenno L, et al. Effects of aerosolized interferon-alpha in patients with pulmonary tuberculosis. Am J Respir Crit Care Med 1998; 158:1156-62.
41. Algood HM, Chan J, Flynn JL. Chemokines and tuberculosis. Cytokine Growth Factor Rev 2003; 14:467-77.
42. Delgado JC, Tsai EY, Thim S, et al. Antigen-specific and persistent tuberculin anergy in a cohort of pulmonary tuberculosis patients from rural Cambodia. Proc Natl Acad Sci USA 2002; 99:7576-81.
43. Hussain R, Toossi Z, Hasan R, Jamil B, Dawood G, Ellner JJ. Immune response profile in patients with active tuberculosis in a BCG vaccinated area. Southeast Asian J Trop Med Public Health 1997; 28:764-73.
44. Magnani ZI, Confetti C, Besozzi G, et al. Circulating, Mycobacterium tuberculosis-specific lymphocytes from PPD skin test-negative patients with tuberculosis do not secrete interferon-γ (IFN-γ) and lack the cutaneous lymphocyte antigen skin-selective homing receptor. Clin Exp Immunol 2000; 119:99-106.
45. Surcel HM, Troye-Blomberg M, Paulie S, et al. Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens. Immunology 1994; 81:171-6.
46. Turner J, Corrah T, Sabbally S, Whittle H, Dockrell HM. A longitudinal study of in vitro IFN-γ production and cytotoxic T cell responses of tuberculosis patients in The Gambia. Tuber Lung Dis 2000; 80:161-9.
47. Ordway DJ, Costa L, Martins M, et al. Increased interleukin-4 production by CD8 and γδ T cells in health-care workers is associated with the subsequent development of active tuberculosis. J Infect Dis 2004; 190:756-66.
48. Rook GA, Dheda K, Zumla A. Do successful tuberculosis vaccines need to be immunoregulatory rather than merely Th1-boosting? Vaccine 2005; 23:2115-20.